{
    "code": 0,
    "data": [
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3FY26 Earnings Call Transcript",
            "news_id": "a4a44f0f-4e6c-4928-b722-d554598967d4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1082d0ab-d6fb-40f5-873e-d7301397cd05.pdf",
            "news_date": "2026-02-04 19:48:05",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Q3FY26 Earnings Call Audio Recording",
            "news_body": "Q3FY26 Earnings Call audio recording",
            "news_id": "4620c544-0021-4550-af07-aeec6c5da570",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe19d494-870f-4508-af81-37b62c0dc0b8.pdf",
            "news_date": "2026-01-31 20:21:02",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended 31 December 2025",
            "news_body": "Unaudited Financial Results for the quarter and nine months ended 31 December 2025",
            "news_id": "af69f8f3-dc5b-42ba-a5c5-1516cb437c66",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f98cd836-0498-41d3-835b-bd611455ba9d.pdf",
            "news_date": "2026-01-31 14:26:50",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "SPIL Investor Presentation -Dec 2025",
            "news_id": "fc6a41dc-b184-4414-ad54-9b57d768b24e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e01bfcbf-aaae-4101-a746-c13ec04f062e.pdf",
            "news_date": "2025-12-26 14:51:31",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2 FY26 Earnings Call Transcript",
            "news_id": "e26ec7d2-55b4-48cd-b724-f1f69f2d1fad",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97dcb020-6882-4de1-8e04-97d06256d293.pdf",
            "news_date": "2025-11-11 16:00:05",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Investor Call Audio Recording",
            "news_body": "Investor Call Audio Recording",
            "news_id": "44c50472-487a-4e61-874e-9c0dba0f9b62",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=12a54720-8836-40fc-840f-875a4672d699.pdf",
            "news_date": "2025-11-05 20:30:41",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half-Year Ended 30 September 2025",
            "news_body": "Financial Results for the quarter and half-year ended 30 September 2025",
            "news_id": "dd3ed724-bccd-4f79-a747-33862a544fb3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=962c537c-a0c8-4613-98b2-cbcdcac6ce9e.pdf",
            "news_date": "2025-11-05 16:05:00",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation -Aug 2025",
            "news_id": "d9a935c9-b4c8-44ad-8601-3550a0590b9b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53bd47d5-f08c-4abf-89dc-c111d452ca8e.pdf",
            "news_date": "2025-09-01 17:34:12",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q1 FY26 Earnings Call Transcript",
            "news_id": "2a9fa3a5-0c93-4cab-8235-39b10a607026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9f2ef68-3852-4c76-b699-37803a05f264.pdf",
            "news_date": "2025-08-06 16:55:57",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Sun Pharmas Q1FY26 Investor Call Audio Recording",
            "news_body": "Sun Pharmas Q1FY26 Investor Call Audio Recording",
            "news_id": "d23fd9e1-05fd-4abc-bdbe-63769fb1ffdf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e66f48fa-6352-44dd-9294-df434c2faa89.pdf",
            "news_date": "2025-07-31 20:32:23",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30 June 2025",
            "news_body": "Financial results for the quarter ended 30 June 2025",
            "news_id": "f2ccb6e8-7dec-4f6d-9470-959f6e019e52",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e83bf6df-02b2-4f7a-b8a7-5beb96ab4ab6.pdf",
            "news_date": "2025-07-31 14:35:42",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "SPIL Investor Presentation -July 2025",
            "news_id": "5e69baee-6e2d-40cf-8f8c-c02cd6bd8054",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=811dac05-9dcf-4c75-8db4-54806ab875d4.pdf",
            "news_date": "2025-07-14 18:48:59",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4 FY25 Earnings Call Transcript",
            "news_id": "222dabd2-70b1-4810-8fab-fd47a7774ce0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3466942d-443e-4c97-8148-54b3f242e619.pdf",
            "news_date": "2025-05-29 17:33:06",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Investor Audio Call Recording",
            "news_body": "Investor Audio Call Recording",
            "news_id": "f3228dde-4022-4653-8216-1bf8d5e8f580",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b296a88-054e-4726-bc5e-c9f69697814f.pdf",
            "news_date": "2025-05-22 20:57:14",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended 31 March 2025",
            "news_body": "Audited Financial Results",
            "news_id": "1dc36a44-195e-4850-98f5-4383f67be6c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=74b39d7e-b0fa-481a-b99a-827ad86869a7.pdf",
            "news_date": "2025-05-22 17:18:45",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation -Feb 2025",
            "news_id": "4b5d8a56-e9da-428c-b394-948a6437eb3f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34807459-abf9-47bd-ae8e-0c309ade4bfc.pdf",
            "news_date": "2025-03-04 17:02:48",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3 FY25 Earnings Call Transcript",
            "news_id": "01ea8d52-3bfc-4a5e-83d4-a906a56c665b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c64727af-4734-40b3-9dd8-dab45dd96e83.pdf",
            "news_date": "2025-02-06 15:24:06",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Q3FY25 Investor Call Audio Recording",
            "news_body": "Q3 FY25 Investor Call Audio Recording",
            "news_id": "840561da-ae11-45f7-b437-3de674f93d18",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d9f19cb-9059-4a8e-9733-e086fb69605c.pdf",
            "news_date": "2025-01-31 20:38:21",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of The Board Meeting Held Today I.E. January 31 2025",
            "news_body": "Outcome of Board Meeting",
            "news_id": "d0e87c86-9b04-4707-94bc-fda1f90bda36",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf1218a0-7999-4c14-9df5-b8ff85b5bd34.pdf",
            "news_date": "2025-01-31 15:12:39",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation -Nov 2024",
            "news_id": "90448497-455e-4dd6-b4a0-e45a61c33197",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=589346d5-d3f2-4e8b-b7fc-6eb84985195c.pdf",
            "news_date": "2024-11-28 18:11:49",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2 FY25 Earnings call Transcript",
            "news_id": "dd28d98c-8492-4dca-927b-7dd718ce67b9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3bef8197-b43b-4a13-8773-13ec2f811511.pdf",
            "news_date": "2024-11-04 18:02:27",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Q2FY25 Investor Call Audio Recording",
            "news_body": "Q2FY25 Investor Call Audio Recording",
            "news_id": "bfc77359-22f9-4c20-bba4-016f4224a6bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9df09b3-0c74-4ab7-b612-9a338c2f6368.pdf",
            "news_date": "2024-10-28 20:53:28",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Financial results for quarter and half year ended September 30, 2024",
            "news_id": "68cd056e-734b-418b-ac20-d1421779cfac",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89bd56cb-e924-44cb-8e38-401eb373d3ca.pdf",
            "news_date": "2024-10-28 14:38:24",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "276597fa-e403-40f5-bcc3-2fc700ac3962",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1a69652-c883-440b-9e3f-81881aaf438e.pdf",
            "news_date": "2024-09-30 17:31:30",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "SPIL Q1FY25 Earning Call Trascript",
            "news_id": "f7a470e7-dada-4f1f-968e-5d45d24ece09",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bca3c3b-b79b-4111-af68-679a2038beae.pdf",
            "news_date": "2024-08-07 19:00:06",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Investor Call Audio Recording",
            "news_body": "Q1FY25 - Investor Call audio recording",
            "news_id": "19e6714c-adb8-4406-b353-909428b89a66",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef09dd3f-f956-4b5e-8670-7b9a5f9b82f8.pdf",
            "news_date": "2024-08-01 20:21:55",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For Q1 Of FY 2024-25",
            "news_body": "Outcome of Board Meeting",
            "news_id": "3e69dc9b-0a4a-4225-a025-b5095bd9ec60",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2f4547b3-faf6-41d9-8f4d-91c71d429b4f.pdf",
            "news_date": "2024-08-01 14:11:46",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "SPIL-Investor Presentation",
            "news_id": "1177dcd6-7884-43d8-8d46-a7ce04c784b7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c61aaa1c-2fbc-4700-a3aa-ae2a122aca3d.pdf",
            "news_date": "2024-07-10 16:41:23",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4 FY24 Earnings Call Transcript",
            "news_id": "474481a1-6bf9-4405-b124-c28001679db5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee40a7ec-017e-41e7-9f33-2453153e8620.pdf",
            "news_date": "2024-05-29 15:56:44",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation -March 2024",
            "news_id": "1ff0343b-b88a-4223-8d84-819198068b87",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff736ef8-33c8-4fe9-a862-2cf0b401de14.pdf",
            "news_date": "2024-03-14 17:09:19",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "SPIL Q3FY24 Earnings Call Transcript",
            "news_id": "f3410c5e-983e-403a-a16b-cf3ddfc2e93d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d1a8ff3-6340-4b43-b2fa-35c24c711620.pdf",
            "news_date": "2024-02-06 18:27:11",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Q3FY24 Investor Call Audio Recording Link",
            "news_body": "Q3FY24 Investor Call Audio Recording Link",
            "news_id": "2d55fd08-8162-471f-a941-d3e3991b1be9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0bcd396-9017-45f6-8a29-f53fcf850ca6.pdf",
            "news_date": "2024-01-31 20:41:08",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Unaudited Financial Results for the quarter and nine months ended December 31, 2023",
            "news_id": "f0ddebe7-69fc-40f9-88ff-a901900cf2aa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27fe62a4-23fb-429a-b5b6-9fe74421f880.pdf",
            "news_date": "2024-01-31 14:13:46",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "SPIL Investor Presentation January 2024",
            "news_id": "855c4788-f796-47cf-8922-5dc0b1c8ef03",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22f3cd0c-85d8-4c55-9983-e0c8b5d3a9fd.pdf",
            "news_date": "2024-01-04 14:29:59",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q2FY24 Earnings Call Transcript",
            "news_id": "58b5ba86-3f5c-4da2-99ac-6ae4307a43c5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=788eb9c4-2be4-4e46-a1bc-045cc355fed6.pdf",
            "news_date": "2023-11-08 17:56:50",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Outcome of the Board meeting",
            "news_id": "18863a81-02c1-40e5-801b-d3938d84bbe3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea1440c2-4c93-499b-9bdf-3432c2d19904.pdf",
            "news_date": "2023-11-01 13:23:28",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation -Sept 2023",
            "news_id": "0e6076ae-15ad-4d70-be40-cb5f8e34847c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5893923-3593-415f-a2b6-0e52610a6264.pdf",
            "news_date": "2023-09-11 14:26:19",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q1 FY24 Earnings Call Transcript",
            "news_id": "f83956bb-6a74-4ce7-8425-772ed884855a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c02c76d9-0d38-41a3-8a4c-ae60c04d7c6b.pdf",
            "news_date": "2023-08-09 15:08:35",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Investor Call Audio Recording",
            "news_body": "Investor Call Audio Recording",
            "news_id": "0dcaa35d-a2aa-457d-9fed-c6356d4e5625",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3fe4868-0822-4781-82d4-58292f7ea21e.pdf",
            "news_date": "2023-08-03 21:11:16",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "As per the letter attached.",
            "news_id": "ee958e0f-c2c5-4d09-b181-8bb093b83efd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1000850-5ff1-46da-9b87-4a2e91f9c477.pdf",
            "news_date": "2023-08-03 14:05:19",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation -July 2023",
            "news_id": "b98e3407-0437-43ac-ba7a-7465e89b8e7c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=186c7eb4-fbec-475c-b752-496a796a1850.pdf",
            "news_date": "2023-07-21 12:51:42",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q4 FY23 Earnings Call Transcript",
            "news_id": "0a3d0cd5-2db3-46ef-a2e7-85713271768a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=146e73bc-f72d-4970-8bf4-85e4a62ab2f7.pdf",
            "news_date": "2023-05-31 14:26:23",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Q4FY23 Investor Call Audio Recording",
            "news_body": "Q4FY23 Investor call audio recording",
            "news_id": "b588ba60-0c84-4947-b3e4-74e2cebfd6cc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ac81949f-514b-4bfc-87a4-5e243ec32526.pdf",
            "news_date": "2023-05-26 21:46:03",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter And Year Ended March 31, 2023",
            "news_body": "With reference to the intimation of Board meeting submitted on May 11, 2023, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. May 26, 2023 which commenced at 10:40 a.m. and ended at 02:35 p.m., wherein the Board has, inter-alia,  <BR> <BR> 1. Approved Financial Results for the fourth quarter and year ended March 31, 2023 <BR> 2. Recommended Final Dividend for financial year 2022-23",
            "news_id": "5f6f4b02-04f5-43e5-895c-a36e8f2219bd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2796ea31-ed5a-4b54-b289-67239158f9bf.pdf",
            "news_date": "2023-05-26 14:47:51",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "2b7a4ff4-1dda-4b9a-a2a5-43cad8949032",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8698f2bc-87dd-4f1d-89c3-9e9e378d051d.pdf",
            "news_date": "2023-04-28 17:13:33",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Q3 FY23 Earnings Call Transcript",
            "news_id": "4c11bc96-a05a-4eca-9add-2fd345005c20",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e485b9cb-e649-4a5b-a99b-bdf8198f3bf1.pdf",
            "news_date": "2023-02-01 20:10:52",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Investor Call Audio Recording",
            "news_body": "Q3FY23 Investor call audio recording",
            "news_id": "8a492eba-896b-44f7-b5f8-7161db3ea72c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b41bc75-6e98-45c6-93d3-62780419c83f.pdf",
            "news_date": "2023-02-01 08:27:35",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "With reference to the intimation of Board meeting submitted on January 16, 2023, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. January 31, 2023 which commenced at 10:00 a.m. and ended at 01:20 p.m. The Board has, inter-alia,  <BR> <BR> Approved Financial Results for the quarter and nine months ended December 31, 2022 <BR> <BR> Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we enclose herewith the Unaudited Standalone and Consolidated Financial Results of the Company and its subsidiaries for the quarter and nine months ended December 31, 2022, along with the Limited Review Reports thereon.<BR>",
            "news_id": "a80a59ed-2137-48f6-bfdb-2c1fd3b89037",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8744cd2-139b-4755-8f0b-fd5b8df9145d.pdf",
            "news_date": "2023-01-31 13:28:22",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "SPIL Investor Presentation",
            "news_id": "c2f28c6d-53fc-4b58-ad3d-9b8cde6e88d1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a746248f-0105-4089-98c4-ba102ee0cc86.pdf",
            "news_date": "2023-01-16 16:47:52",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Intimation Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the disclosure of related party transactions for the half year ended September 30, 2022 is enclosed herewith.",
            "news_id": "0939a630-1a8d-438d-9eea-93351fb583b4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85f1bb55-6b0e-4112-a72e-2f0f543dcc75.pdf",
            "news_date": "2022-11-16 12:23:36",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Company's Q2FY23 earnings conference call.",
            "news_id": "ba1908f6-3d88-4932-999d-8f8ded0fe88e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ce16a4d-da5c-414e-ae88-048e3e9386e0.pdf",
            "news_date": "2022-11-05 21:26:02",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "With reference to the intimation of Board meeting submitted on October 10, 2022, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. November 01, 2022 which commenced at 10:10 am and ended at 01:10 pm. The Board has, inter-alia,  <BR> <BR> 1.  Approved Financial Results for the quarter and half year ended September 30, 2022 <BR> <BR> 2.  Approved and recommended Appointment of Independent Director",
            "news_id": "01e47abe-a133-4cea-a619-d51e8179acab",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5f6804da-f8c1-4896-99f5-d6d3159f0e9c.pdf",
            "news_date": "2022-11-01 13:36:13",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith the investor presentation, which we shall be uploading on our website after sending this letter to you.",
            "news_id": "1a5381a0-73b6-4c7f-8d69-98c11313faf1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1917fd81-3d5b-4335-86c8-e03a677b571c.pdf",
            "news_date": "2022-09-16 17:04:20",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Company's Q1FY23 earnings conference call.",
            "news_id": "6ff8850e-6174-4547-9509-de6d4d9816e7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d6dc697-3de4-4ebd-98c7-bb4a1eae4f4c.pdf",
            "news_date": "2022-08-03 16:56:21",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "With reference to the intimation of Board meeting submitted on July 12, 2022, we wish to inform you that the Meeting of the Board of Directors of the Company was held today i.e. July 29, 2022 which commenced at 10:00 a.m. IST and ended at 01:25 p.m. IST. <BR> <BR> The Board has, inter-alia, approved Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2022.<BR>",
            "news_id": "0f41b831-2758-45de-ba3a-01d15a9d851d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7f7efda3-62da-4ce9-b004-f00c659cae57.pdf",
            "news_date": "2022-07-29 13:39:06",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Intimation Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the disclosure of related party transactions (on consolidated basis) for the half year ended March 31, 2022 is enclosed herewith.",
            "news_id": "2b5400d7-e3c4-41e2-99d0-27480a5599bb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7c5af49-8657-44bc-bdd8-3d249da3f695.pdf",
            "news_date": "2022-06-14 17:51:45",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Company's Q4FY22 earnings conference call.",
            "news_id": "95fbd1c9-545f-4b6c-9402-f2b586d1d98a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29210495-3f9c-418e-ae83-9e7328b8e485.pdf",
            "news_date": "2022-06-02 18:08:02",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Q4FY22 Earnings Call Audio Recording",
            "news_id": "84e227f2-3108-43eb-ad6c-8cb92f7b0a92",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27d1b97d-a6dd-4b51-adf9-920f9331539d.pdf",
            "news_date": "2022-05-30 21:36:23",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Year Ended March 31, 2022",
            "news_body": "Attached",
            "news_id": "560baf21-b190-4115-ae7e-8328a21fcf55",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b974b285-f201-434a-8777-6b19699f34b3.pdf",
            "news_date": "2022-05-30 15:30:44",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith the investor presentation.",
            "news_id": "a6aca996-ebc0-48af-a07d-17dddf068129",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=339a0c90-0174-4550-afb8-583c664106d2.pdf",
            "news_date": "2022-03-24 16:12:57",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Company's Q3FY22 earnings conference call.",
            "news_id": "03b2e1f4-5aa2-4658-96f8-fafb0091a692",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c96f5127-18f1-4664-8ac5-5cca09a0d4be.pdf",
            "news_date": "2022-02-03 17:33:51",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "1. Approval Of Unaudited Financial Statements For The Quarter And Nine Months Ended December 31, 2021;<BR> 2. Declaration Of An Interim Dividend For The Financial Year Ending On March 31, 2022 And Fixing Of Record Date For The Same.<BR> 3. & 4. Change In The Company Secretary & Compliance Officer Of The Company",
            "news_body": "As per the letter attached",
            "news_id": "22002cf0-e0f9-403a-8bd2-e250688b8ccf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4dd229d6-fef6-4fe4-8844-36cb300f3397.pdf",
            "news_date": "2022-01-31 13:45:10",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Company''s Q2FY22 earnings conference<BR> call.",
            "news_id": "bf771161-0ac7-42a3-b025-b77f4d3279f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a4d3ebd-410c-47fc-964a-76d80ffb8f53.pdf",
            "news_date": "2021-11-11 15:11:35",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "The Board of Directors of the Company at its meeting held today i.e. November 02, 2021 has inter alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2021.<BR> Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we enclose herewith the following as 'Annexure':<BR> a) Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2021.<BR> b) Limited  Review  Report  of  the  Statutory  Auditors  of  the  Company  on  Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2021.<BR> The meeting of the Board of Directors of the Company commenced at 10:30 a.m. and concluded at 01:10 p.m.<BR>",
            "news_id": "3fab0ad4-d59b-4175-a65a-553eebe7b882",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51259527-894f-40ca-81c4-3570cd731c78.pdf",
            "news_date": "2021-11-02 13:28:04",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "The Board of Directors of the Company at its meeting held today i.e. November 02, 2021 has inter alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2021.<BR> Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we enclose herewith the following as 'Annexure':<BR> a) Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2021.<BR> b) Limited  Review  Report  of  the  Statutory  Auditors  of  the  Company  on  Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2021.<BR> The meeting of the Board of Directors of the Company commenced at 10:30 a.m. and concluded at 01:10 p.m.<BR>",
            "news_id": "518099d3-8823-4d52-9751-d4300ce13426",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6433c54-a75b-4bab-9334-b58d00cde3b7.pdf",
            "news_date": "2021-11-02 13:15:58",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith a copy of the transcript of the Company's Q1FY22 earnings conference call.",
            "news_id": "2a6af7c7-08bb-44bb-8e98-56043aa5ca1c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11d850b2-ea51-4b85-b41a-6fbe75675d86.pdf",
            "news_date": "2021-08-06 15:37:47",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2021",
            "news_body": "The Board of Directors of the Company at its meeting held today i.e. July 30, 2021 has inter alia considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2021.<BR> <BR> Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we enclose herewith the following as 'Annexure':  <BR> <BR> a) Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter ended June 30, 2021. <BR> <BR> b) Limited Review Report of the Statutory Auditors of the Company on Unaudited (Standalone and Consolidated) Financial Results for the quarter  ended June 30, 2021. <BR>  <BR> The meeting of the Board of Directors of the Company commenced at 10.15 a.m. and concluded at 1:45 p.m.",
            "news_id": "a57f7aed-3ea5-4d9a-9f3f-7166685aa0d1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ab06ce7-1913-43dd-ad83-0257e2609d5d.pdf",
            "news_date": "2021-07-30 13:55:38",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of the Company's Q4FY21 earnings conference call.",
            "news_id": "cd834f18-2498-4af1-aacc-a12e5d08e343",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d619b226-40c2-4d83-b719-81a9d1ced632.pdf",
            "news_date": "2021-06-02 18:02:18",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "1) Approval Of Audited Standalone And Consolidated Financial Statements For The Quarter And Year Ended March 31, 2021.<BR> 2) Recommendation Of Payment Of Final Dividend For The Financial Year Ended March 31, 2021.<BR> <BR>",
            "news_body": "As per letter attached",
            "news_id": "397e3cef-1f16-4e2a-b135-d8b92b089e43",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=194b8268-fc8b-4874-91b1-c2b17a44bf87.pdf",
            "news_date": "2021-05-27 15:55:59",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "SUNPHARMA",
            "disp": "Sun Pharmaceutical",
            "bse_code": 524715,
            "isin": "INE044A01036",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result - Audited Financial Results For The Quarter And Year Ended March 31, 2021, Recommended Final Dividend",
            "news_body": "As per letter attached",
            "news_id": "9bc08a5b-af6e-401c-8ff6-8baf7d2a5ba3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=befc3d37-aa69-43e7-8acd-ad41705845d8.pdf",
            "news_date": "2021-05-27 15:53:13",
            "seo": "sun-pharmaceutical-ltd",
            "ltp": 1711.1,
            "ch": 3.2999999999999545,
            "pch": 0.19323105750087566,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 3351,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}